SGA
SAGE

Sector Gamma AS’s Sage Therapeutics SAGE Stock Holding History

Sector Gamma AS’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-115,696
Closed -$4.53M – 36
2022
Q3 		$4.53M Sell
115,696
-2,780
-2% -$107K 1.17% 21
2022
Q2 		$3.83M Hold
118,476
– – 0.86% 27
2022
Q1 		$3.92M Buy
118,476
+19,572
+20% +$736K 0.85% 31
2021
Q4 		$4.21M Sell
98,904
-11,863
-11% -$497K 0.99% 27
2021
Q3 		$4.91M Buy
110,767
+20,029
+22% +$919K 0.98% 27
2021
Q2 		$5.16M Buy
+90,738
New +$6.41M 0.91% 30

Other funds holding SAGE

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Sector Gamma AS's SAGE Position: Q4 2022 in Review

Sector Gamma AS sold out of Sage Therapeutics (SAGE) in Q4 2022, closing a stake of 115,696 shares — an estimated $4.53M sold.

Sector Gamma AS first reported a position in SAGE in Q2 2021 and held it in 6 quarters. The position peaked at $5.16M in Q2 2021. 206 funds tracked by Wall St. Rank hold SAGE as of Q4 2022.

  • Sector Gamma AS reported no remaining Sage Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Sector Gamma AS sold 115,696 Sage Therapeutics shares in Q4 2022, an estimated $4.53M.
  • Sector Gamma AS first reported a position in Sage Therapeutics in Q2 2021 and held it in 6 quarters.
  • Sector Gamma AS's Sage Therapeutics position peaked at $5.16M in Q2 2021.
  • 206 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2022.

Based on Sector Gamma AS's 13F filing for Q4 2022, filed 7 Feb 2023.